Hot Penny Stocks in News - JOURNAL RADIOLOGY in (OTC:JRRD), Growlife Inc (OTC:PHOT), Cord Blood America Inc. (OTC:CBAI)

Stamford, CT -- (SBWIRE) -- 02/21/2013 -- Jet Life Penny Stocks provides investors with the hot penny stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletters and offer you the tools to help you along the way with the goal of keeping you loyal to our service.

JOURNAL RADIOLOGY IN (OTC:JRRD) opened its shares at the price of $0.001 for the day, its closing price was $0.0007 after losing -30.00% for the day. The company traded with the total volume of 19.83 million shares while its average trading aptitude remained 5.76million shares.

Have a look on the company’s graph: During last 5 trades the stock plummeted almost -30%. During last one month it slipped with the percentage of -82.5. Its year to date performance remained progressive with -96.5%.

Can Investors Bet on JRRD after this News update? Find out in this Research Report

52-week price range of the stock remained $0.0007 - $0.20, while during last trade its minimum price was $0.0007 and it gained highest price of $0.001.

Growlife Inc (OTC:PHOT) percentage change reduced -5.53% to close at $0.0735 with the total traded volume of 18.65 million shares more than average volume of 12.00 million.

Company’s year to date performance remained quiet optimistic with the rise of 98.65%. If we look at last 6 months of trade that is in bullish zone with an increase of 163.44%

Is PHOT a Solid Investment at These Levels? Read This Report For Details

Its beta value stands at 75.95 times. The company has total of 343.57 million outstanding shares and its total market capitalization is $25.25 million.

52-week price range of the stock remained $0.01 - $0.25, while during last trade its minimum price was $0.06 and it gained highest price of $0.08. GrowLife, Inc. (PHOT), a provider of highly effective indoor growing technologies, announced that it has entered into a strategic licensing letter of intent with GrowLife Consulting Colorado, LLC ("GLCC"). Under the agreement, GLCC is authorized to use the name "GrowLife" in Colorado, as well as certain intellectual property and technology rights in exchange for licensing fees.

Cord Blood America Inc. (OTC:CBAI) started its trading session with the price $0.0034, and closed at price of $0.0032 by decreasing -5.88%.Day trading range of CBAI was $0.003 -$0.0034.

A review of its graph: Previous 5 days graph demonstrated a negative move of 14.29%. CBAI’s quarterly performance remained red with the percentage of -28.89, while its year to date performance showed that the stock plunged overall -36%.The beta of the CBAI stands at -0.77.

How Should Investors Trade CBAI Now? Don’t Miss out a Special Trend Analysis

CBAI’s stocks traded with total volume of 15.68 million shares while the average trading capacity remained 10.31 million shares. Cord Blood America, Inc., through its subsidiaries, provides private cord blood stem cell preservation services to families throughout the United States and internationally in South America, China, Germany, and Spain. It services include collection of materials, physician and customer support, transportation, and comprehensive testing. The company is headquartered in Las Vegas, Nevada.

About Jetlifepennystock.com
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to.Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.

Disclaimer
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.